448 related articles for article (PubMed ID: 35716169)
21. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
22. Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010.
Chen YH; Lu PL; Huang CH; Liao CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Ko WC; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR
Antimicrob Agents Chemother; 2012 Mar; 56(3):1452-7. PubMed ID: 22203598
[TBL] [Abstract][Full Text] [Related]
23. Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center - 6 years' experience.
Lee CY; Chen PY; Huang FL; Lin CF
J Microbiol Immunol Infect; 2009 Apr; 42(2):160-5. PubMed ID: 19597649
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of nosocomial pneumonia in infants after cardiac surgery.
Tan L; Sun X; Zhu X; Zhang Z; Li J; Shu Q
Chest; 2004 Feb; 125(2):410-7. PubMed ID: 14769717
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial resistance and pathogen distribution in hospitalized burn patients: A multicenter study in Southeast China.
Li L; Dai JX; Xu L; Chen ZH; Li XY; Liu M; Wen YQ; Chen XD
Medicine (Baltimore); 2018 Aug; 97(34):e11977. PubMed ID: 30142829
[TBL] [Abstract][Full Text] [Related]
26. The interface between COVID-19 and bacterial healthcare-associated infections.
O'Toole RF
Clin Microbiol Infect; 2021 Dec; 27(12):1772-1776. PubMed ID: 34111586
[TBL] [Abstract][Full Text] [Related]
27. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
Piérard D; Stone GG
BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017).
Ko WC; Stone GG
Ann Clin Microbiol Antimicrob; 2020 Apr; 19(1):14. PubMed ID: 32238155
[TBL] [Abstract][Full Text] [Related]
29. [An analysis of resistance of nosocomial infection pathogens isolated from 13 teaching hospitals in 2011].
Chen HB; Zhao CJ; Wang H; Cao B; Xu XL; Chu YZ; Hu ZD; Zhuo C; Hu BJ; Liu WE; Liao K; Zhang R; Zeng J; Wang Y; Luo YP; Wang ZW; Liu YM; Chen X; Tian B; Su DH; Zhou CM; Zou MX; Guo PH; Zhou HW; Jin Y
Zhonghua Nei Ke Za Zhi; 2013 Mar; 52(3):203-12. PubMed ID: 23856111
[TBL] [Abstract][Full Text] [Related]
30. Bloodstream infections and antibiotic resistance patterns: a six-year surveillance study from southern Italy.
Foglia F; Della Rocca MT; Melardo C; Nastri BM; Manfredini M; Montella F; De Filippis A; Finamore E; Galdiero M
Pathog Glob Health; 2023 Jun; 117(4):381-391. PubMed ID: 36190133
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of pathogenic bacteria and drug resistance in neonatal purulent meningitis].
Zhu M; Hu Q; Mai J; Lin Z
Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):51-6. PubMed ID: 25748405
[TBL] [Abstract][Full Text] [Related]
32. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
Zarakolu P; Hasçelik G; Unal S
Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study.
Tian L; Sun Z; Zhang Z
BMC Public Health; 2018 Sep; 18(1):1121. PubMed ID: 30219056
[TBL] [Abstract][Full Text] [Related]
34. [Causative agents of intravenous catheter-related infections and their antibiotic susceptibilities].
Aktaş E; Sarı EN; Seremet Keskin A; Pişkin N; Külah C; Cömert F
Mikrobiyol Bul; 2011 Jan; 45(1):86-92. PubMed ID: 21341163
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic Resistance Profile of Common Bacteria Isolated from Blood Stream, Lower Respiratory Tract and Urinary Infections in Intensive Care Unit in Saudi Arabia: A Retrospective Study.
Kabrah AM; Kabrah SM; Bahwerth FS; Alredaini NF
Ethiop J Health Sci; 2021 Nov; 31(6):1231-1240. PubMed ID: 35392341
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017).
Tian L; Zhang Z; Sun Z
Antimicrob Resist Infect Control; 2019; 8():86. PubMed ID: 31161033
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019.
Jean SS; Ko WC; Hsueh PR;
Int J Antimicrob Agents; 2020 Jul; 56(1):106016. PubMed ID: 32422316
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
Sader HS; Castanheira M; Flamm RK
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
[TBL] [Abstract][Full Text] [Related]
39. A 12-Year Retrospective Analysis of Blood Culture Isolates in the Intensive Care Unit of a Tertiary Hospital in China.
Peng Z; Wang Y; Jia L; Jiang Y; Li X
Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649502
[TBL] [Abstract][Full Text] [Related]
40. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
